Loading…
InfuSystem Holdings, Inc. is projected to rise to $12.78 by 2027, a +32% move from its current price of $9.68. INFU is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $9.42 | $9.68 | $9.95 | +0.01% |
| Jul 14 | $9.32 | $9.68 | $10.06 | +0.01% |
| Jul 15 | $9.24 | $9.68 | $10.15 | +0.02% |
| Jul 16 | $9.17 | $9.68 | $10.22 | +0.03% |
| Jul 17 | $9.12 | $9.68 | $10.29 | +0.03% |
| Jul 18 | $9.06 | $9.68 | $10.35 | +0.04% |
| Jul 19 | $9.02 | $9.68 | $10.40 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.02 | $9.68 | $10.40 | +0.05% |
| Week 2 | $8.76 | $9.69 | $10.72 | +0.09% |
| Week 3 | $8.57 | $9.69 | $10.97 | +0.14% |
| Week 4 | $8.41 | $9.70 | $11.19 | +0.19% |
| Week 5 | $8.27 | $9.70 | $11.38 | +0.24% |
| Week 6 | $8.15 | $9.71 | $11.56 | +0.28% |
| Week 7 | $8.04 | $9.71 | $11.73 | +0.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InfuSystem Holdings, Inc. is a healthcare company that provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.
The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers.
The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
InfuSystem Holdings, Inc. (INFU) is currently priced at $10.05 and has a market cap of $202.83M, ranking 3804 by market capitalization.
The near-term forecast for 2026 shows an average price of $10.05 with a low of $7.42 and a high of $13.08, and a predicted ROI of 0, with sentiment listed as NEUTRAL.
Looking further out, the forecast curve points to bullish upside, with 2027 average near $14.01 and rising to higher levels over the decade, including 2030 near $21.65, 2040 near $58.13, and 2050 near $115.37. The maximums in those years reach $31.15 (2030), $96.53 (2040), and $208.88 (2050), reflecting substantial upside potential along the way.
A major floor 16.1% below — a decisive break under it would weaken the trend.
The nearest floor, 9.6% below — buyers have tended to step in here.
The nearest ceiling, 5.0% above — a clean break opens room to run.
A major ceiling 13.0% above — clearing it would confirm fresh momentum.
Key INFU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INFU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.76 | Sell | $9.74 | Sell |
| MA 10 | $9.85 | Sell | $9.70 | Sell |
| MA 20 | $9.44 | Buy | $9.55 | Buy |
| MA 50 | $9.35 | Buy | $9.43 | Buy |
| MA 100 | $9.40 | Buy | $9.34 | Buy |
| MA 200 | $9.32 | Buy | $9.06 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.32 | Neutral |
| Stoch RSI (14) | 43.41 | Neutral |
| CCI (20) | 38.98 | Neutral |
| Williams %R (14) | -38.71 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 6.61 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 61.29 | Neutral |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | 0.42 | Buy |
| Ultimate (7,14,28) | 52.69 | Neutral |
| Momentum (10) | 0.63 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 9.65 | Buy |
| ADX (14) | 11.85 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is bullish. RSI14 is 50, and the price is trading above the key moving averages, with SMA50 at $9.45 and SMA200 at $9.33, suggesting light upside momentum.
The nearest defined support is at $8.21 and the immediate resistance is at $10.16, framing a near-term range around the current price. The 30-day price range spans from $8.48 to $11.91, indicating tolerance for modest fluctuations within the emerging uptrend.
Annualized volatility is 50%, underscoring meaningful short-term risk despite the constructive setup.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.42 | $9.68 | $12.50 | 0% | Neutral | |
| $10.18 | $12.78 | $16.96 | +32% | Bullish | |
| $12.97 | $16.73 | $23.03 | +73% | Bullish | |
| $13.47 | $17.78 | $25.18 | +84% | Bullish | |
| $14.41 | $19.40 | $28.15 | +100% | Bullish | |
| $15.11 | $20.73 | $30.72 | +114% | Bullish | |
| $15.75 | $21.98 | $33.19 | +127% | Bullish | |
| $17.79 | $25.22 | $38.74 | +161% | Bullish | |
| $20.57 | $29.61 | $46.20 | +206% | Bullish | |
| $23.63 | $34.50 | $54.63 | +256% | Bullish | |
| $31.01 | $48.37 | $81.43 | +400% | Bullish | |
| $54.53 | $95.30 | $175.41 | +885% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $7.42 | $9.68 | $11.89 | +0.00% |
| August 2026 | $8.47 | $10.00 | $12.12 | +3.29% |
| September 2026 | $8.20 | $9.74 | $11.93 | -2.58% |
| October 2026 | $8.27 | $9.88 | $12.22 | +1.48% |
| November 2026 | $8.43 | $10.13 | $12.62 | +2.46% |
| December 2026 | $8.25 | $9.96 | $12.50 | -1.67% |
Click any year to see its month-by-month INFU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INFU to range from $7.42 to $12.50 through 2026. The $9.68 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The INFU price prediction for 2027 points to an average of $12.78 (low $10.18, high $16.96) — a potential gain of +32% on today's $9.68. Momentum favours further upside here.
In 2028, INFU is projected to trade between $12.97 and $23.03, averaging $16.73 — a potential gain of +73% from today's $9.68. That is up +31% on the projected 2027 average. Buyers look set to stay in control over this stretch.
InfuSystem Holdings, Inc.'s 2029 outlook centres on $17.78, within a $13.47 to $25.18 range. That is up +6% on the projected 2028 average. That marks a +84% change versus current levels. Momentum favours further upside here.
By 2030, INFU could reach as high as $28.15, with a base case around $19.40 and support toward $14.41 — roughly +100% from $9.68. Buyers look set to stay in control over this stretch.
Expect INFU to range from $15.11 to $30.72 through 2031. The $20.73 average target implies a +114% move from current prices. That is up +7% on the projected 2030 average. Momentum favours further upside here.
The INFU price prediction for 2032 points to an average of $21.98 (low $15.75, high $33.19) — a potential gain of +127% on today's $9.68. Buyers look set to stay in control over this stretch.
In 2033, INFU is projected to trade between $17.79 and $38.74, averaging $25.22 — a potential gain of +161% from today's $9.68. That is up +15% on the projected 2032 average. Momentum favours further upside here.
InfuSystem Holdings, Inc.'s 2034 outlook centres on $29.61, within a $20.57 to $46.20 range. That is up +17% on the projected 2033 average. That marks a +206% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, INFU could reach as high as $54.63, with a base case around $34.50 and support toward $23.63 — roughly +256% from $9.68. Momentum favours further upside here.
Expect INFU to range from $31.01 to $81.43 through 2040. The $48.37 average target implies a +400% move from current prices. That is up +40% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The INFU price prediction for 2050 points to an average of $95.30 (low $54.53, high $175.41) — a potential gain of +885% on today's $9.68. Momentum favours further upside here.
Investing $1,000 in INFU today (≈ 103.305785 INFU) could be worth
$9,845.15
+$8,845.15 (+885%) by 2050 · US Dollar
Based on the average projected INFU price of $95.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INFUwould be worth at today's price.
$1,000 invested in INFU on Jul 10, 2025 (≈ 161.550887 INFU) would be worth
$1,563.81
+$563.81 (+56.4%) today · 1.56× · US Dollar
Based on a INFU entry price of $6.19 vs. today's $9.68.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.16 | $952.76 | -4.7% |
| 1 month ago | $8.88 | $1,090.09 | +9.0% |
| 3 months ago | $9.38 | $1,031.98 | +3.2% |
| 6 months ago | $8.74 | $1,107.55 | +10.8% |
| 1 year ago | $6.19 | $1,563.81 | +56.4% |
| All time (5.0y) ago | $18.92 | $511.63 | -48.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INFU forecast.
Our base-case forecast reaches $19.00 around 2030.
Implied market cap at $19.00: $383.45M
The multi-year forecast shows a clear, bullish trajectory from 2027 onward, with rising average prices and substantial upside potential. For 2026 the average price is $10.05 with a min of $7.42 and a max of $13.08, and a neutral sentiment.
By 2027 the average is projected to $14.01 (ROI 39.4) and by 2028 to $18.15 (ROI 80.6). The trajectory continues with 2029 at $19.13 (ROI 90.3) and 2030 at $21.65 (ROI 115.4), reflecting accelerating gains.
From 2031 through 2035, the forecast shows continued expansion: 2031 $23.37 (ROI 132.6), 2032 $24.68 (ROI 145.5), 2033 $29.46 (ROI 193.1), 2034 $34.44 (ROI 242.7), and 2035 $39.65 (ROI 294.5). The rise culminates in 2040 at $58.13 (ROI 478.4) and 2050 at $115.37 (ROI 1047.9), all with bullish sentiment.
These are forecast estimates, not guarantees, and actual results may differ due to market conditions and other factors.
Tap a question to reveal the answer.
Avg $21.65, min $16.19, max $31.15; ROI 115.4; sentiment BULLISH.
Forecast shows bullish sentiment from 2027 onward with rising averages and ROI, reaching 132.6 by 2031 and 1047.9 by 2050; 2026 is neutral with avg $10.05 and ROI 0. These are estimates, not guarantees.
The 2040 forecast max is $96.53 and the 2050 max is $208.88, so reaching $50 is possible within the forecast window, with substantial upside by 2040 or 2050.
Current price is $10.05 and market cap is $202.83M, with a rank of 3804.
Avg $10.05; min $7.42; max $13.08; ROI 0; sentiment NEUTRAL.
InfuSystem Holdings, Inc. Community Discussion
0Share your InfuSystem Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.